Related Experiment Video
Updated: Dec 12, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Differential Impact of Cognitive Impairment in MCI Patients: A Case-Based Report
Valentina Pergher1,2, Birgitte Schoenmakers3, Philippe Demaerel4
1Department of Cognitive Neuropsychology, Harvard University, Cambridge, Massachusetts, USA.
Abstract:
Mild cognitive impairment (MCI) traditionally refers to an intermediate stage between healthy individuals and early Alzheimer disease. Evidence shows grey and white matter volume changes and decrease in several executive functions, albeit the relation between cognitive performance and brain volume remains unclear. Here, we discuss 3 individual cases of MCI by investigating their MRI scans and cognitive test performance. We also recruited age-matched healthy older adults serving as gold standard for both grey and white matter volume and cognitive test outcomes. Our results show the impact of cognitive impairment on cognitive test performance and grey and white matter volumes, and the role played by cognitive and brain reserve on mitigating cognitive decline. Furthermore, we add evidence to previous studies by showing an increase in white matter volume compared to healthy controls, in all 3 patients. This pattern of increased white matter volume might help us to better understand the pathological mechanisms underlying MCI which in turn could contribute to future investigations.
Insights
Mild cognitive impairment (MCI) involves changes in brain volume and executive functions. This study found increased white matter volume in MCI patients, offering insights into disease mechanisms.
Area of Science:
- Neuroscience
- Gerontology
- Medical Imaging
Background:
- Mild cognitive impairment (MCI) is a transitional stage between normal aging and Alzheimer's disease.
- Existing research indicates grey and white matter volume alterations and executive function deficits in MCI.
- The precise relationship between cognitive performance and brain volume in MCI remains incompletely understood.
Observation:
- This study examined three individual cases of MCI using MRI scans and cognitive assessments.
- Age-matched healthy older adults were included as controls for comparison of brain volumes and cognitive outcomes.
- The investigation focused on the interplay between cognitive function, grey matter, and white matter volumes.
Findings:
- Cognitive impairment significantly impacts both cognitive test performance and brain volumes (grey and white matter).
- Cognitive and brain reserve appear to play a role in mitigating cognitive decline associated with MCI.
- Notably, all three MCI patients exhibited increased white matter volume compared to healthy controls, a finding that warrants further investigation.
Implications:
- The observed increase in white matter volume in MCI patients provides novel evidence for pathological mechanisms.
- Understanding these mechanisms can enhance diagnostic approaches and therapeutic strategies for MCI.
- This research contributes to a deeper comprehension of MCI, potentially aiding in early detection and intervention for Alzheimer's disease.
- Further research into white matter volume changes could refine our understanding of cognitive reserve and resilience.
More Related Videos
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....
The Influence of Affect on Cognition
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...